MedTech Commercialisation Advancement Program
MedTech Commercialisation Advancement Program (MCAP)
The MIME MCAP provides focused assistance to early-stage technologies developed by teams of multidisciplinary medical technology innovators from universities and healthcare facilities.
The MCAP provides expertise, support, and capability enhancement to both projects and individuals over an 8-10-week period. The program incorporates inputs and skills from business, design, healthcare professionals and experienced MedTech developers, resulting in a detailed curriculum plan and various design, business and commercialisation assets in order to take projects beyond the ‘plateau’.
The program plays an important role in fostering a culture of innovation and entrepreneurship at Monash and beyond. Key benefits include accelerating the commercialisation capability of research teams, and supporting progression in product development journeys.
The MCAP pilot program was initially funded by the Victorian Government through the Australian MedTech Manufacturing Centre and successfully completed over an 18-month period in 2023 with six promising MedTech innovator teams selected.
Now the MCAP program, funded by MIME, works to benefit our MedTech ecosystem.
Read more about MIME's MedTech Commercialisation Advancement Program (MCAP) in the AusBioTech Journal.
In the News
Meet Professor Jess Frith from the MedTech Commercialisation Advancement Program (MCAP)
The MIME MedTech Commercialisation Advancement Program (MCAP) provides focused assistance to early stage technologies developed by teams of multidisciplinary medical technology innovators from universities and healthcare facilities. We spoke to Professor Jess Frith who was involved in the MIME MCAP program during 2024.
Meet Dr Alexandra Ure from the MIME MedTech Commercialisation Advancement Program (MCAP)
The MIME MedTech Commercialisation Advancement Program (MCAP) provides focused assistance to early stage technologies developed by teams of multidisciplinary medical technology innovators from universities and healthcare facilities. We spoke to Dr Alexandra Ure who was involved in the MIME MCAP program during 2024.
Meet Dr Sudha Mokkapati from the MIME MedTech Commercialisation Advancement Program (MCAP)
The MIME MedTech Commercialisation Advancement Program (MCAP) provides focused assistance to early stage technologies developed by teams of multidisciplinary medical technology innovators from universities and healthcare facilities. We spoke to Dr Sudha Mokkapati who was involved in the MIME MCAP program during 2024.
For further information on the MedTech Commercialisation Advancement Program (MCAP) contact Dr Andrew Carey, MIME Prorgram Manager or Shama Kazmi, MIME Project Manager.